Biomedical research institute advancing genomics, proteomics, and cancer therapeutics
Broad Institute operates a large-scale research organization spanning genomics, proteomics, chemical biology, and cancer therapeutics across three organizational structures: core labs, programs, and platforms. The tech stack reflects a hybrid research environment—AWS, GCP, Python, R, Jupyter for computational work; specialized instruments (10x Genomics, Illumina, LC-MS) for wet-lab operations; and enterprise systems (SAP, Jira, Confluence) for coordination. Current hiring is research-heavy (25 of 49 open roles), with mid-level scientists dominating the pipeline, while SAP migration (ECC → S/4HANA) and pain points around financial reporting standardization and lab IT integration suggest operational scaling challenges.
Notable leadership hires: Operations Director
The Broad Institute is a nonprofit biomedical research organization founded in 2003 as a partnership between MIT and Harvard, based in Cambridge, MA. The institute brings together undergraduate and graduate students, postdoctoral fellows, professional scientists, and faculty to tackle problems in human biology and disease. Organizational structure includes core member laboratories, programs, and platforms; researchers work across institutional boundaries and with global collaborators. Active research programs span genomics sequencing and analysis, cancer biology, cell circuits, therapeutics discovery, proteomics, metabolite profiling, imaging, chemical biology, and RNAi. Scale: 1,001–5,000 employees; all hiring currently in the United States.
AWS, GCP, Python, R, Java, SQL, Jupyter, Apache Airflow for computational work; 10x Genomics, Illumina sequencers, LC-MS, BD Rhapsody for lab instruments; SAP (transitioning from ECC to S/4HANA), Jira, Confluence, Smartsheet for operations.
Cambridge, MA. Founded in 2003 as a partnership between MIT and Harvard. Current employee range: 1,001–5,000.
Other companies in the same industry, closest in size